A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis

scientific article published on 26 October 2007

A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/ARD.2007.078832
P698PubMed publication ID17965124

P50authorRene E ToesQ42494390
Annette H. van der Helm-van MilQ67408980
P2093author name stringHuizinga TW
Allaart CF
van der Kooij SM
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
P304page(s)769-774
P577publication date2007-10-26
P1433published inAnnals of the Rheumatic DiseasesQ4767876
P1476titleA high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis
P478volume67

Reverse relations

cites work (P2860)
Q47772154A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs
Q45787030A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis
Q93054220A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases
Q33950766Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.
Q37380362Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis
Q47734526Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions
Q47325126Are obesity and rheumatoid arthritis interrelated?
Q57788293Association of High Body Mass Index With Decreased Treatment Response to Combination Therapy in Recent-Onset Rheumatoid Arthritis Patients
Q47885394Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset.
Q64119496Associations between Adipokines in Arthritic Disease and Implications for Obesity
Q39710835Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis
Q33632098Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis
Q58234801Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis
Q38763702Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations
Q51013068Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).
Q37358808Body mass index and extent of MRI-detected inflammation: opposite effects in rheumatoid arthritis versus other arthritides and asymptomatic persons
Q39296233Body mass index and response to abatacept in rheumatoid arthritis
Q87142111Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study
Q36198718Body mass index and the rheumatoid arthritis swollen joint count: an observational study
Q39164961Can Rheumatologists Predict Eventual Need for Orthopaedic Intervention in Patients with Rheumatoid Arthritis? Results of a Systematic Review and Analysis of Two UK Inception Cohorts
Q28082992Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis?
Q26744334Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps
Q39993473Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis
Q92224136Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis
Q36999878Contribution of obesity to the rise in incidence of rheumatoid arthritis
Q99630709Effect of Body Mass Index on the Disease Activity of Patients With Rheumatoid Arthritis in a Gender-Specific Manner and the Association of Respective Serum C-Reactive Protein Levels With the Body's Inflammatory Status
Q34189534Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats.
Q92542142Fat-Produced Adipsin Regulates Inflammatory Arthritis
Q34330638Fatty acids, lipid mediators, and T-cell function
Q48338337Functional and phenotypical analysis of IL-6-secreting CD4+ T cells in human adipose tissue
Q34450993Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study
Q36732733Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years
Q38767940Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohorts
Q36326901Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis
Q33750548Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis
Q34089998Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.
Q36297290Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients
Q45953403Lack association of body mass index with disease activity composites of rheumatoid arthritis in Korean population: cross-sectional observation.
Q33575341Lack of association of high body mass index with risk for developing polymyalgia rheumatica
Q26822038Metabolic syndrome in rheumatoid arthritis
Q64229233Myopenia is associated with joint damage in rheumatoid arthritis: a cross-sectional study
Q89099319Obesity Associated With Active, but Preserved Joints in Rheumatoid Arthritis: Results From our National Registry
Q36120756Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation
Q26778275Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response
Q89523046Obesity and its role in the management of rheumatoid and psoriatic arthritis
Q34488394Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).
Q37801496Obesity in rheumatoid arthritis
Q44368185Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis
Q48874324Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients
Q64125008Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis
Q92003457Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis
Q46176650Patterns and predictors of joint damage as assessed by the rheumatoid arthritis articular damage (RAAD) score in South Africans with established rheumatoid arthritis.
Q35065164Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage?
Q36784187Predictors of longterm changes in body mass index in rheumatoid arthritis
Q51333035Predictors of severe radiographic progression in patients with early rheumatoid arthritis: A Prospective observational cohort study.
Q39091655Prevalence of overweight in Moroccan patients with rheumatoid arthritis and its relationships with disease features
Q47202397Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies
Q38569273Response to 'Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis'.
Q37385755Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases
Q38236740Rheumatoid arthritis and metabolic syndrome
Q37774545Rheumatoid cachexia and cardiovascular disease.
Q51187397Risk factors associated with the occurrence of distal radius fractures in Japanese patients with rheumatoid arthritis: a prospective observational cohort study.
Q64982546Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction.
Q37690729Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort
Q55267199Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.
Q58042690Systemic disease sequelae in chronic inflammatory diseases and chronic psychological stress: comparison and pathophysiological model
Q28074864The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care
Q34139272The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis
Q36000249The challenging interplay between rheumatoid arthritis, ageing and comorbidities
Q36148660Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis
Q51667223Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis.
Q35045933Utility of different cardiovascular disease prediction models in rheumatoid arthritis
Q64078464Vitamin D Receptor Gene Polymorphism: An Important Predictor of Arthritis Development

Search more.